文献速递脑血管病

颈动脉血管重建与药物治疗对伴同侧颈动脉蹼缺血性卒中的比较:系统综述与荟萃分析

Carotid Revascularization Versus Medical Management for Ischemic Stroke with Ipsilateral Carotid Web: A Systematic Review and Meta-Analysis.
PubMed 文献 · Ann Neurol · 2025-06-12

该系统综述与荟萃分析纳入17项观察性研究,比较药物治疗与颈动脉血管重建对同侧颈动脉蹼相关缺血性卒中的疗效。药物治疗组32%(90/281)患者出现同侧复发性缺血性卒中,血管重建显著降低复发风险(RR 0.11,95%CI 0.06-0.28,p<0.001,I2=14.5%)。颈动脉内膜切除术与颈动脉支架置入术疗效无显著差异(RR 0.44,95%CI 0.11-1.76,p=0.99)。

要点

  • 颈动脉蹼相关卒中药物治疗后同侧复发率高达32%,需重视复发风险。
  • 颈动脉血管重建可显著降低同侧复发性缺血性卒中风险(RR 0.11)。
  • 颈动脉内膜切除术与支架置入术在降低复发风险上无显著差异。

核心结论

  • 颈动脉血管重建与降低同侧复发性缺血性卒中风险相关,且血管重建亚型(颈动脉内膜切除术与颈动脉支架置入术)间无差异。

研究设计与样本

  • 系统综述与荟萃分析,注册于PROSPERO(CRD42024485069),检索Embase、Scopus、MEDLINE、Web of Science和CINAHL五个数据库,纳入17项观察性研究(16项已发表和1项机构研究)。

主要发现

  • 药物治疗组32%(90/281)患者发生同侧颈动脉蹼复发性缺血性卒中。
  • 荟萃分析显示血管重建组复发性缺血性卒中风险显著更低(RR 0.11,95%CI 0.06-0.28,p<0.001,I2=14.5%)。
  • 颈动脉内膜切除术与颈动脉支架置入术降低复发性卒中风险无显著差异(RR 0.44,95%CI 0.11-1.76,p=0.99)。

关键数值与推荐

  • 药物治疗包括抗血小板和抗凝治疗。
  • 主要比较指标为复发性缺血性卒中风险比(RR)及95%置信区间。

临床怎么用

  • 对于伴同侧颈动脉蹼的缺血性卒中患者,可考虑颈动脉血管重建以降低复发风险。
  • 血管重建方式选择(内膜切除术或支架置入术)可根据患者具体情况个体化决定。

局限性

  • 纳入研究样本量小且异质性高。
  • 药物治疗下颈动脉蹼的自然病史不确定。
  • 缺乏前瞻性对照比较有效性研究,结论需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Carotid artery web is an underrecognized cause of ischemic stroke and is associated with a high risk of recurrent events. It is uncertain whether medical management or carotid revascularization is beneficial for patients with ischemic stroke and ipsilateral carotid web. In the absence of large randomized clinical trials and observational studies, we performed a systematic review and meta-analysis comparing medical management and carotid revascularization in this population. METHODS: The systematic review was registered in PROSPERO (CRD42024485069). We searched five databases: Embase, Scopus, MEDLINE, Web of Science, and CINAHL. We included observational studies that studied the association between recurrent stroke in patients with ipsilateral carotid web receiving medical management (antiplatelet and anticoagulation) and carotid revascularization. Random effects modeling was performed, and risk ratio with 95% confidence intervals were reported. RESULTS: We included 17 studies (16 published and 1 institutional study). In the medical management group, 32% (90/281) of patients experienced recurrent ischemic stroke ipsilateral to the carotid web. The meta-analysis revealed a significantly lower risk of recurrent ischemic stroke with carotid revascularization (relative risk 0.11, 95% confidence interval 0.06-0.28, p < 0.001, I2 = 14.5%). Both carotid endarterectomy and carotid artery stenting were equally effective in reducing recurrent stroke risk (relative risk 0.44, 95% confidence interval 0.11-1.76, p = 0.99). INTERPRETATION: Carotid revascularization is associated with reduced recurrence rates, with no difference between revascularization subtypes (carotid endarterectomy vs carotid artery stenting). However, given the small, heterogeneous cohorts and the uncertain natural history of carotid artery web under medical management, these findings should be interpreted with caution until prospective, controlled comparative effectiveness studies are performed. ANN NEUROL 2025;98:625-633.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Khan F, Rehman CA, Fletcher L, et al. Carotid Revascularization Versus Medical Management for Ischemic Stroke with Ipsilateral Carotid Web: A Systematic Review and Meta-Analysis. Ann Neurol. 2025. PMID: 40503762. doi:10.1002/ana.27280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。